AbbVie Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | — | $10.0M |
| FY2011 | — | — | $27.0M |
| FY2012 | $14.63B | $-350.0M | $5.90B |
| FY2013 | $14.29B | $4.49B | $9.60B |
| FY2014 | $10.54B | $1.74B | $8.35B |
| FY2015 | $29.24B | $3.95B | $8.40B |
| FY2016 | $36.44B | $4.64B | $5.10B |
| FY2017 | $30.95B | $5.10B | $9.30B |
| FY2018 | $35.00B | $-8.45B | $7.29B |
| FY2019 | $67.23B | $-8.17B | $39.92B |
| FY2020 | $84.95B | $13.08B | $8.45B |
| FY2021 | $75.96B | $15.41B | $9.75B |
| FY2022 | $63.13B | $17.25B | $9.20B |
| FY2023 | $59.25B | $10.36B | $12.81B |
| FY2024 | $66.84B | $3.33B | $5.52B |
| FY2025 | $64.50B | $-3.27B | $5.23B |